STOCK TITAN

XENE (NASDAQ: XENE) Rule 144 Notice — 3,750 RSUs Vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

XENE Rule 144 notice reporting proposed and recent transactions in Common Shares. The filing lists 3,750 Restricted Share Units vesting on 03/12/2026 and shows 2,607 Common Shares sold by Andrea DiFabio on 03/10/2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the XENE Form 144 disclose about RSU vesting?

The Form 144 reports a Restricted Share Unit award vesting of 3,750 Common Shares on 03/12/2026. This line item is described as an issuer vesting event; the filing does not state subsequent sale plans for those vested shares.

How many shares did Andrea DiFabio sell according to the XENE filing?

The filing shows Andrea DiFabio sold 2,607 Common Shares on 03/10/2026. The notice lists the sale quantity and date; it does not specify sale price or purchaser details.

Does the Form 144 state whether the company receives proceeds from the sales?

The Form 144 excerpt does not state the recipient of sale proceeds. It lists the securities, vesting date, and a recent sale, but does not specify whether proceeds accrue to the issuer or selling holders.

What exchange is XENE listed on in this filing?

The filing indicates the Common Shares are listed on NASDAQ. The excerpt includes listing venue information but does not provide market prices or trading volumes.

Are there other recent transactions reported in the Form 144 excerpt?

Yes. Besides the 3,750 RSU vesting on 03/12/2026, the excerpt records a sale of 2,607 shares by Andrea DiFabio on 03/10/2026. No additional recent transactions are shown in the provided excerpt.
Xenon Pharmaceut

NASDAQ:XENE

View XENE Stock Overview

XENE Rankings

XENE Latest News

XENE Latest SEC Filings

XENE Stock Data

4.82B
82.14M
Biotechnology
Pharmaceutical Preparations
Link
Canada
BURNABY